Clinicians in the UK are quickly re-thinking their approach to treating immunocompromised cancer patients during widespread community transmission of the COVID-19 infection. In correspondence published in the British Journal of Haematology, a team from Oxford warned of the urgent need to “consider the unique impact this [COVID-19] may have on haematology patients and the practical ...
COVID-19: UK cancer clinicians told to use less immunosuppressive chemotherapy
By Emma Wilkinson
18 Mar 2020